Copley Acquisition Corp signs definitive merger with Ignite Proteomics; $150M equity value

Copley Acquisition Corp

Aggregate Merger Consideration is $150M ($10.00 per Pubco share), payable in Pubco common stock.
Pubco to pay $4M cash to Sponsor Payment Recipient at closing; Sponsor distinct from Sponsor.
Closing requires ≥$15M SPAC trust cash (after redemptions) and ≥$7.5M net proceeds from Ignite's financing.
Post-closing board: 7 members designated by Ignite, ≥4 independent; CEO/CFO to be Ignite's current officers.
Termination date: Sept 30, 2026; if SPAC Minimum Cash Condition unmet, Copley reimburses Ignite up to $1.5M.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Copley Acquisition Corp entered into Business Combination Agreement with Ignite Proteomics, LLC, Ignite Proteomics Holdings, Inc., and others valued at $150,000,000 (effective 2026-06-10).

Action: entry
Agreement: merger
Counterparty: Ignite Proteomics, LLC, Ignite Proteomics Holdings, Inc., and others
Value: $150,000,000
Effective: 2026-06-10

Exact text from the filing

On June 10, 2026, Copley Acquisition Corp, a Cayman Islands exempted company (“ Copley ” or “ SPAC ”), entered into a Business Combination Agreement (the “ Business Combination Agreement ”) with Ignite Proteomics, LLC

View on SEC.gov

801 material agreements filed in the last 30 days. Browse all material agreements →

Copley Acquisition Corp filing history →

Source: SEC EDGAR

accession 0001829126-26-006336

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.